A Phase II Study of Paclitaxel/Cisplatin Combination in Patients with Metastatic Breast Cancer Refractory to Anthracycline-Based ChemotherapyGerardo Rosati, G Pacilio, P. De Rosa et al.|Tumori Journal|2000Cited by 17
Evaluation of TAG-72 as a serum marker in ovarian and breast carcinoma.Gennaro Esposito, Marco Salvatore, G Pacilio et al.|PubMed|1991Cited by 3
A phase II study of octreotide in metastatic advanced prostatic cancer (MAPC)A. Tucci, G Pacilio, Giacomo Cartenì et al.|European Journal of Cancer and Clinical Oncology|1991Cited by 2
Phase II trial of paclitaxel (P) and cisplatin (COOP) in patients with advanced breast cancer refractory to anthracycline (A) therapyFerdinando Riccardi, G Pacilio, G. Rosati et al.|European Journal of Cancer|1997Cited by 1
Protracted infusion (PI) of 5-FU+FA in advanced colorectal cancerFerdinando Riccardi, G Pacilio, A. Tucci et al.|European Journal of Cancer and Clinical Oncology|1991Cited by 0